Valerie Coppenrath to Humans
This is a "connection" page, showing publications Valerie Coppenrath has written about Humans.
Connection Strength
0.086
-
Coppenrath V, Mazyck B. Tirzepatide (Zepbound) for the Treatment of Obesity. Am Fam Physician. 2024 08; 110(2):199-200.
Score: 0.034
-
Coppenrath VA, Hydery T. Dapagliflozin/Saxagliptin Fixed-Dose Tablets: A New Sodium-Glucose Cotransporter 2 and Dipeptidyl Peptidase 4 Combination for the Treatment of Type 2 Diabetes. Ann Pharmacother. 2018 Jan; 52(1):78-85.
Score: 0.021
-
Coppenrath V, Filosa LA, Akselrod E, Carey KM. Adaptation and Validation of the Fresno Test of Competence in Evidence-Based Medicine in Doctor of Pharmacy Students. Am J Pharm Educ. 2017 Aug; 81(6):106.
Score: 0.021
-
Bylo M, Farewell R, Coppenrath VA, Yogaratnam D. A Review of Deflazacort for Patients With Duchenne Muscular Dystrophy. Ann Pharmacother. 2020 08; 54(8):788-794.
Score: 0.006
-
Mukherjee MS, Coppenrath VA, Dallinga BA. Pharmacologic management of types 1 and 2 diabetes mellitus and their complications in women of childbearing age. Pharmacotherapy. 2015 Feb; 35(2):158-74.
Score: 0.004